Hemo Organic (HEMORGANIC) | Stock Overview & Key Data

Hemo Organic Ltd. | Small-cap | Healthcare

₹9.26

-9.83%

Hemo Organic vs Sun Pharmaceutical Hemo Organic vs Divi's Laboratories Hemo Organic vs Innova Captab Hemo Organic vs Sequent Scientific Hemo Organic vs Sun Pharma Advanced Hemo Organic vs NIFTY 50 | Market

Chart Range Statistics Financials Returns Ownership Calculator FAQ

Hemo Organic Performance Comparison

Loading chart data...

Performance Summary

Interactive charts require JavaScript. Here's the essential performance data:

Period	Hemo Organic	Healthcare Sector	NIFTY 50
1 Week	-2.42%	N/A	N/A
1 Month	-4.34%	N/A	N/A
3 Months	-11.05%	N/A	N/A
6 Months	-0.75%	N/A	N/A
1 Year	-20.17%	N/A	N/A
3 Years	-59.74%	N/A	N/A
5 Years	-20.17%	N/A	N/A

Stock Range

Today's Range

Low: ₹9.26 High: ₹10.19

on September 19, 2025

52 Week Range

Low: ₹8.05 High: ₹13.70

on February 28, 2025

on December 30, 2024

All-Time High: ₹2,386.00 on April 21, 2008

Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights

Key Statistics

Market Cap i INR33.5M

EPS i 0.23

P/E Ratio (TTM) i 44.87

Forward P/E i N/A

P/B Ratio i -21.72

PEG Ratio i 0.02

Div. Yield i N/A

ROE i -108.18%

Beta i -0.056

Debt to Equity i -9.77

Financial Highlights

Profitability

Gross Margin i 26.32%

Operating Margin i -6,026.32%

Profit Margin i 3.28%

Returns and Earnings

Return on Assets (TTM) i 3.29%

Return on Equity (TTM) i -108.18%

EBITDA i INR256.0K

Net Income (TTM) i INR815.0K

Growth

Revenue (TTM) i

Revenue Per Share (TTM) i INR7.17

Quarterly Revenue Growth (YoY) i -99.92%

Quarterly Earnings Growth (YoY) i N/A

Peer Performance Comparison

Performance comparison table showing returns for peer companies over various time periods
Company	Market Cap	1W	1M	3M	6M	YTD	1Y	3Y	5Y
Hemo Organic HEMORGANIC	33.48M Small-cap	-2.42%	-4.34%	-11.05%	-0.75%	-18.99%	-20.17%	-59.74%	-20.17%
Sun Pharmaceutical SUNPHARMA	3.94T Large-cap	2.44%	1.81%	0.51%	-4.41%	-12.38%	-11.24%	79.79%	238.20%
Divi's Laboratories DIVISLAB	1.62T Large-cap	2.88%	1.98%	-4.51%	6.56%	2.09%	13.75%	70.21%	102.56%
Innova Captab INNOVACAP	49.37B Small-cap	0.17%	-4.49%	3.01%	-1.92%	-22.38%	8.33%	59.05%	59.05%
Sequent Scientific SEQUENT	46.87B Small-cap	9.93%	13.87%	6.68%	38.79%	8.66%	15.68%	88.39%	37.14%
Sun Pharma Advanced SPARC	46.74B Small-cap	0.13%	-2.56%	-4.87%	9.93%	-28.61%	-34.40%	-34.02%	-14.84%

Ownership & Short Interest

Insider Ownership i 41.95%

Institutional Ownership i 0.00%

Shares Short i N/A

Short Ratio i N/A

Short % of Shares Outstanding i N/A

Average 10-Day Volume i 4K

Average 90-Day Volume i 3K

Recurring Investment / Dollar-Cost Averaging Calculator

Calculate how a regular investment in would have performed over time.

Calculator Requires JavaScript

The investment calculator requires JavaScript to perform real-time calculations. Please enable JavaScript for the full experience.

Alternative: Manual Calculation

For historical performance data of , please visit the price history page to analyze returns manually.

Recent Performance Summary:

1 Week: -2.42%
1 Month: -4.34%
3 Months: -11.05%
1 Year: -20.17%

Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.

Frequently Asked Questions

What is HEMORGANIC's 52-week high and low?

In the last 52 weeks, Hemo Organic reached a high of ₹13.70 (on December 30, 2024) and a low of ₹8.05 (on February 28, 2025).

What is the market cap and P/E ratio for HEMORGANIC?

Curious about Hemo Organic's size and valuation? Its market capitalization stands at 33.48M. When it comes to valuation, the P/E ratio (trailing twelve months) is 44.87, and the forward P/E (looking ahead) is N/A.

Does HEMORGANIC pay dividends? If so, what's the yield?

As for dividends, Hemo Organic isn't currently offering a significant yield, or that specific data isn't available right now.

Who are Hemo Organic's main competitors or similar companies to consider before investing?

When looking at Hemo Organic, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:

Company	Mkt Cap	Sector	Industry	1Y Return	3Y Return
Sun Pharmaceutical SUNPHARMA	3.94T	Healthcare	Drug Manufacturers - Specialty & Generic	-11.24%	79.79%
Divi's Laboratories DIVISLAB	1.62T	Healthcare	Drug Manufacturers - Specialty & Generic	13.75%	70.21%
Innova Captab INNOVACAP	49.37B	Healthcare	Drug Manufacturers - Specialty & Generic	8.33%	59.05%
Sequent Scientific SEQUENT	46.87B	Healthcare	Drug Manufacturers - Specialty & Generic	15.68%	88.39%
Sun Pharma Advanced SPARC	46.74B	Healthcare	Drug Manufacturers - Specialty & Generic	-34.40%	-34.02%

For a more comprehensive list, please see the Peer Performance Comparison table on this page.

What are the key financial health indicators for Hemo Organic Ltd.? (e.g., ROE, Debt/Equity)

To get a sense of Hemo Organic's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -108.18%, the Debt to Equity ratio from the most recent quarter is -9.77, and its Gross Profit Margin stands at 26.32%.

What is the recent revenue and earnings growth for HEMORGANIC?

Looking at Hemo Organic's growth, its revenue over the trailing twelve months (TTM) was INR25M. Compared to the same quarter last year (YoY), quarterly revenue grew by -99.92%, and quarterly earnings saw a YoY growth of N/A.

How much of HEMORGANIC stock is held by insiders and institutions?

Wondering who owns Hemo Organic stock? Company insiders (like executives and directors) hold about 41.95% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 0.00%.

For more common questions about our data, please visit our About Data page.

Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.